DK363887A - USE OF BROMCRUPTIN - Google Patents

USE OF BROMCRUPTIN

Info

Publication number: DK363887A
Authority: DK; Denmark
Prior art keywords: bromcruptin
Prior art date: 1986-07-14

Application number

DK363887A

Other languages

Danish (da)

Other versions

DK363887D0 (en

Inventor

Douglas Larson

Peter Hiestand

Original Assignee

Sandoz Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1986-07-14

Filing date

1987-07-13

Publication date

1988-01-15

1987-07-13 Application filed by Sandoz Ag filed Critical Sandoz Ag

1987-07-13 Publication of DK363887D0 publication Critical patent/DK363887D0/en

1988-01-15 Publication of DK363887A publication Critical patent/DK363887A/en

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Epidemiology (AREA)
Immunology (AREA)
Endocrinology (AREA)
Reproductive Health (AREA)
Urology & Nephrology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

DK363887A 1986-07-14 1987-07-13 USE OF BROMCRUPTIN DK363887A (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US88511086A	1986-07-14	1986-07-14

Publications (2)

Publication Number	Publication Date
DK363887D0 DK363887D0 (en)	1987-07-13
DK363887A true DK363887A (en)	1988-01-15

Family

ID=25386156

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK363887A DK363887A (en)	1986-07-14	1987-07-13	USE OF BROMCRUPTIN

Country Status (13)

Country	Link
JP (1)	JPS6323817A (en)
KR (1)	KR880001292A (en)
AU (1)	AU602154B2 (en)
CH (1)	CH672987A5 (en)
DE (1)	DE3722383A1 (en)
DK (1)	DK363887A (en)
FR (1)	FR2601245A1 (en)
GB (1)	GB2192541B (en)
IT (1)	IT1224222B (en)
NL (1)	NL8701631A (en)
PH (1)	PH24525A (en)
SE (1)	SE8702843L (en)
ZA (1)	ZA875145B (en)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE3814521A1 (en) *	1987-05-07	1988-11-17	Sandoz Ag	NEW APPLICATION OF DOPAMINE RECEPTOR AGONISTS
EP0327040A3 (en) *	1988-02-05	1990-11-28	Predrag Dr.Sc. Sikiric	Use of dopamine and/or dopamine agonists to prepare a medicine for the treatment of the digestive tract
US5585347A (en) *	1988-05-10	1996-12-17	Ergo Science Incorporated	Methods for the determination and adjustment of prolactin daily rhythms
US5468755A (en) *	1988-05-10	1995-11-21	The Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College	Therapeutic process for the treatment of the pathologies of Type II diabetes
US5744477A (en) *	1988-05-10	1998-04-28	The Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College	Method for treatment of obesity using prolactin modulators and diet
US5830895A (en) *	1988-05-10	1998-11-03	The Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College	Methods for the determination and adjustment of prolactin daily rhythms
US5668155A (en) *	1988-05-10	1997-09-16	The General Hospital Corporation	Administration of pirenzepine, methyl scopolamine and other muscarinic receptor antagonists for treatment of lipid metabolism disorders
US5716932A (en) *	1988-05-10	1998-02-10	Louisiana State University And Agricultural And Mechanical College	Process for the long term reduction of body fat stores, insulin resistance, and hyperinsulinemia in vertebrates
US6004972A (en) *	1988-05-10	1999-12-21	The Board Of Supervisiors Of Louisiana State University And Agricultural And Mechanical College	Therapeutic process for the treatment of the pathologies of type II diabetes
US5700800A (en) *	1988-05-10	1997-12-23	Ergo Science Incorporated	Methods for the long term reduction of body fat stores, insulin resistance, hyperinsulinemia and hyperglycemia in vertebrates with a prolactin stimulatory compound
US5344832A (en) *	1990-01-10	1994-09-06	The Board Of Supervisors Of Louisiana University And Agricultural And Mechanical College	Method for the long term reduction of body fat stores, insulin resistance, hyperinsulinemia and hyperglycemia in vertebrates
CA2030174C (en) *	1990-01-10	1996-12-24	Anthony H. Cincotta	Process for the long term reduction of body fat stores, insulin resistance, hyperinsulinemia and hypoglycemia in vertebrates
WO1993012793A1 (en) *	1991-12-23	1993-07-08	The Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College	A therapeutic process for the treatment of the pathologies of type ii diabetes
US5696128A (en) *	1994-07-07	1997-12-09	The Board Of Supervisors Of Louisiana University And Agricultural And Mechanical College	Method of regulating immune function
IL112106A0 (en) *	1993-12-22	1995-03-15	Ergo Science Inc	Accelerated release composition containing bromocriptine
US5714519A (en) *	1995-06-07	1998-02-03	Ergo Science Incorporated	Method for regulating glucose metabolism
US5626860A (en) *	1995-06-07	1997-05-06	The Board Of Supervisors Of Louisana State And Agricultural And Mechanical College	Method for regulating metabolism with dopamine beta hydroxylase inhibitors
US20010016582A1 (en)	1997-04-28	2001-08-23	Anthony H. Cincotta	Method and composition for the treatment of lipid and glucose metabolism disorders
CA2670846C (en)	2006-11-23	2014-12-23	Ergonex Pharma Gmbh	Pharmaceutical compositions for the treatment of capillary arteriopathy
EP3925610A1 (en) *	2016-04-20	2021-12-22	VeroScience LLC	Composition and method for treating metabolic disorders
CA3079522A1 (en)	2017-10-18	2019-04-25	Veroscience Llc	Improved bromocriptine formulations

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CH507249A (en) *	1968-05-31	1971-05-15	Sandoz Ag	Process for the preparation of 2-bromo-a-ergocryptine
GB2154874B (en) *	1984-02-29	1987-11-04	Sandoz Ltd	Bromoscriptine compositions
CH666406A5 (en) *	1984-02-29	1988-07-29	Sandoz Ag	METHOD FOR PRODUCING microcapsules BROMOKRIPTINMESYLAT AS PHARMACOLOGICAL ACTIVE INCLUDED.

1987
- 1987-07-07 DE DE19873722383 patent/DE3722383A1/en not_active Withdrawn
- 1987-07-09 CH CH2611/87A patent/CH672987A5/de not_active IP Right Cessation
- 1987-07-10 NL NL8701631A patent/NL8701631A/en not_active Application Discontinuation
- 1987-07-10 FR FR8709849A patent/FR2601245A1/en not_active Withdrawn
- 1987-07-10 IT IT48160/87A patent/IT1224222B/en active
- 1987-07-10 GB GB8716323A patent/GB2192541B/en not_active Expired - Lifetime
- 1987-07-13 KR KR1019870007490A patent/KR880001292A/en not_active Application Discontinuation
- 1987-07-13 AU AU75587/87A patent/AU602154B2/en not_active Ceased
- 1987-07-13 SE SE8702843A patent/SE8702843L/en not_active Application Discontinuation
- 1987-07-13 DK DK363887A patent/DK363887A/en not_active Application Discontinuation
- 1987-07-13 JP JP62174576A patent/JPS6323817A/en active Pending
- 1987-07-14 PH PH35534A patent/PH24525A/en unknown
- 1987-07-14 ZA ZA875145A patent/ZA875145B/en unknown

Also Published As

Publication number	Publication date
DK363887D0 (en)	1987-07-13
SE8702843D0 (en)	1987-07-13
NL8701631A (en)	1988-02-01
KR880001292A (en)	1988-04-22
IT8748160A0 (en)	1987-07-10
PH24525A (en)	1990-07-18
IT1224222B (en)	1990-09-26
CH672987A5 (en)	1990-01-31
GB8716323D0 (en)	1987-08-19
ZA875145B (en)	1989-02-22
FR2601245A1 (en)	1988-01-15
SE8702843L (en)	1988-01-15
AU7558787A (en)	1988-01-21
DE3722383A1 (en)	1988-01-28
GB2192541A (en)	1988-01-20
AU602154B2 (en)	1990-10-04
GB2192541B (en)	1990-05-02
JPS6323817A (en)	1988-02-01

Publication	Publication Date	Title
DK208188D0 (en)	1988-04-15	USE OF 17-KETOSTEROIDS
DK363887D0 (en)	1987-07-13	USE OF BROMCRUPTIN
DK193588A (en)	1988-10-11	APPLICATIONS OF DOPAMINAGONISTS
DK662687D0 (en)	1987-12-16	USE OF TRICYCLIC CARBAZOLONES
DK185988D0 (en)	1988-04-06	USE OF ANTIGEN
DK38593D0 (en)	1993-03-31	ALCOXYMETHYLETHERS OF GLYCEROLES
DK87888D0 (en)	1988-02-19	THERAPEUTIC USE OF TINDIODDEUTEROPORFYRIN
DK120389D0 (en)	1989-03-13	USE OF PROGESTIN
DK102389D0 (en)	1989-03-02	USE OF INTERLEUKIN
DK104389A (en)	1989-09-05	USE OF IMIDAZOLD DERIVATIVES
DK564886D0 (en)	1986-11-25	FUNGICID USE OF TETRAHYDROBENZOTHIENYLURINE INGREDIENTS
DK541487D0 (en)	1987-10-16	SUMMARY OF MATERIALS
DK293787A (en)	1987-12-11	EXPRESSION OF AN AMYLOGLUCOSIDASE
DK289987A (en)	1987-12-08	USING AVARON AND AVAROLD DERIVATIVES
DK309888D0 (en)	1988-06-07	PREPARATION OF GLYCERALDEHYD-3-PHOSPHATE DEHYDROGENASE
DK237385A (en)	1985-12-01	USE OF DIHYDROERGOTAMINE
DK185987D0 (en)	1987-04-10	APPLICATION OF PROSTAGLANDINES
DK289887A (en)	1987-12-08	USING AVARON AND AVAROLD DERIVATIVES
DK135387D0 (en)	1987-03-17	PREPARATION OF PROTEINS
DK153045C (en)	1988-10-31	CONNECTION OF PRINCIPLES OF EXTENSION
DK333587D0 (en)	1987-06-29	USE OF PYRIDINE DERIVATIVES
ES296589Y (en)	1988-11-16	PARTIAL SET OF PELUCA
SE8603968D0 (en)	1986-09-22	NEW USE
DK0402857T3 (en)	1991-10-09	Use of 17beta-cyclopropylamino-androsten derivatives
DK171389D0 (en)	1989-04-10	USE OF ACETAZOLAMIDE

Legal Events

Date	Code	Title	Description
1992-03-30	AHB	Application shelved due to non-payment